BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7046470)

  • 1. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus.
    Olefsky JM; Kolterman OG; Scarlett JA
    Am J Physiol; 1982 Jul; 243(1):E15-30. PubMed ID: 7046470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus.
    Scarlett JA; Kolterman OG; Ciaraldi TP; Kao M; Olefsky JM
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1195-201. PubMed ID: 6341390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes.
    Olefsky JM; Kolterman OG
    Am J Med; 1981 Jan; 70(1):151-68. PubMed ID: 7006388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus.
    Kolterman OG; Gray RS; Griffin J; Burstein P; Insel J; Scarlett JA; Olefsky JM
    J Clin Invest; 1981 Oct; 68(4):957-69. PubMed ID: 7287908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus.
    Olefsky JM; Revers RR; Prince M; Henry RR; Garvey WT; Scarlett JA; Kolterman OG
    Adv Exp Med Biol; 1985; 189():176-205. PubMed ID: 3898763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity.
    Ciaraldi TP; Kolterman OG; Olefsky JM
    J Clin Invest; 1981 Oct; 68(4):875-80. PubMed ID: 7026616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin receptor- and nonreceptor-controlled cellular substrate processing. A review of clinical studies in the isolated human adipocyte model.
    Pedersen O
    J Endocrinol Invest; 1985 Feb; 8(1):77-87. PubMed ID: 3886773
    [No Abstract]   [Full Text] [Related]  

  • 8. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.
    Pagano G; Cavallo-Perin P; Cassader M; Bruno A; Ozzello A; Masciola P; Dall'omo AM; Imbimbo B
    J Clin Invest; 1983 Nov; 72(5):1814-20. PubMed ID: 6355186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective.
    Olefsky JM
    Diabetes; 1981 Feb; 30(2):148-62. PubMed ID: 7009267
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the glucose transport system in the postreceptor defect in insulin action associated with human aging.
    Fink RI; Kolterman OG; Kao M; Olefsky JM
    J Clin Endocrinol Metab; 1984 Apr; 58(4):721-5. PubMed ID: 6699133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin receptors and action in clinical disorders of carbohydrate tolerance.
    Pollet RJ
    Am J Med; 1983 Nov; 75(5B):15-22. PubMed ID: 6369964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity with insulin resistance: experimental insights.
    Clark MG; Rattigan S; Clark DG
    Lancet; 1983 Nov; 2(8361):1236-40. PubMed ID: 6139579
    [No Abstract]   [Full Text] [Related]  

  • 13. Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia.
    Moller DE; Chang PY; Yaspelkis BB; Flier JS; Wallberg-Henriksson H; Ivy JL
    Endocrinology; 1996 Jun; 137(6):2397-405. PubMed ID: 8641192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance: receptor and post-binding defects in human obesity and non-insulin-dependent diabetes mellitus.
    Truglia JA; Livingston JN; Lockwood DH
    Am J Med; 1985 Aug; 79(2B):13-22. PubMed ID: 3898828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular mechanisms of insulin action: implications for insulin resistance and type II diabetes mellitus.
    Pershadsingh HA; Christensen RL; McDonald JM
    Clin Chem; 1986 Oct; 32(10 Suppl):B19-27. PubMed ID: 3530537
    [No Abstract]   [Full Text] [Related]  

  • 17. Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle.
    Kim JK; Michael MD; Previs SF; Peroni OD; Mauvais-Jarvis F; Neschen S; Kahn BB; Kahn CR; Shulman GI
    J Clin Invest; 2000 Jun; 105(12):1791-7. PubMed ID: 10862794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.
    Olefsky JM; Ciaraldi TP; Kolterman OG
    Am J Med; 1985 Sep; 79(3B):12-22. PubMed ID: 3901744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of insulin resistance in the post receptor events in sheep: 3-O-methylglucose transport in ovine adipocytes.
    Sasaki S
    Horm Metab Res; 1990 Sep; 22(9):457-61. PubMed ID: 2258133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus.
    Kashiwagi A; Verso MA; Andrews J; Vasquez B; Reaven G; Foley JE
    J Clin Invest; 1983 Oct; 72(4):1246-54. PubMed ID: 6355180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.